News | June 16, 2008

GE to Distribute Gamma Medica-Ideas' Pre-Clinical Imaging

June 17, 2008 - Gamma Medica-Ideas and GE Healthcare signed an agreement that GE Healthcare will be the exclusive distributor of Gamma Medica-Ideas' preclinical imaging products effective July 1, 2008, as announced at the 55th annual meeting of the Society of Nuclear Medicine.

Pre-Clinical imaging plays a key role in new pharmaceutical therapeutic development by allowing researchers to visualize the structure, function and response of laboratory animals in vivo.

The agreement complements GE Healthcare's portfolio of pre-clinical products, and grants researchers greater access to GM-I's fully-digital trimodality Positron Emission Tomography (PET); Single Photon Emission Computed Tomography (SPECT) and Computed Tomography (CT) scanners.

"This agreement is an opportunity for customers to gain greater access to our hybrid scanners by leveraging the extensive footprint of GE Healthcare,"? said Bradley Patt, Ph.D., president and CEO of GM-I. "We were first to market a trimodal preclinical scanner, and our all-digital technology provides improved spatial resolution, while enabling researchers to share images easily-bringing digital pathology to the pre-clinical arena."

Gamma Medica-Ideas have installed more than 50 multi-modality systems on four continents since 2002. The company's first-to-market all-digital technologies have made it a leader in pre-clinical imaging systems.

"GE Healthcare is excited to be working with Gamma Medica-Ideas," said Eugene Saragnese, vice president and general manager, molecular imaging and CT, GE Healthcare. "This agreement underscores our deep commitment to the molecular imaging and preclinical markets. Many innovations in clinical imaging get their start in the pre-clinical devices, and we continue to look to that space as a showcase for what's possible for the future of human PET, SPECT and CT imaging."

GE Healthcare already offers dual-modality PET/CT, CZT based SPECT/CT and dedicated in-vivo and specimen preclinical CT scanners. The agreement with GM-I brings scalable and upgradeable tri-modal (PET/SPECT/CT) systems under the GE umbrella.

"Researchers across the globe will reap the benefits of the combined multi-modality pre-clinical portfolio of GE Healthcare and Gamma Medica-Ideas accelerating studies to investigate disease biology and develop new drugs,"? said James Mitchell, general manager, molecular imaging technologies, GE Healthcare. "This agreement makes for a one-stop-shop for pre-clinical imaging devices."

For more information: www.gehealthcare.com

Related Content

MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020
News | Magnetic Resonance Imaging (MRI) | February 28, 2020
February 28, 2020 — MR Solutions will be displaying its la
Nuclear imaging of the spine shown on Philips Healthcare BrightView XCT

Image courtesy of Philips Healthcare

News | Nuclear Imaging | January 27, 2020
January 27, 2020 — According to the new market research report "...
Image by Dr. Manuel González Reyes from Pixabay

Image by Dr. Manuel González Reyes from Pixabay 

News | SPECT Imaging | November 08, 2019
November 8, 2019 — Using ground-breaking technology, researchers at the...
Philips Medical System is recalling its older Forte Gamma Camera SPECT imaging systems due to the possibility of the detectors falling off of the unit onto the patient. The two gamma cameras can bee seen in this photo on either side of the patient bed. These can be rotated above the patient.

Philips Medical System is recalling its older Forte Gamma Camera SPECT imaging systems due to the possibility of the detectors falling off of the unit onto the patient. The two gamma cameras can be seen in this photo on either side of the patient bed. These can be rotated above the patient.

Feature | Nuclear Imaging | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — Philips Medical System is recalling the Forte Gamma Camera System due to the potential for the 660
 Phoenix’s fusion neutron generation technology.
News | Radiopharmaceuticals and Tracers | October 28, 2019
October 28, 2019 — Phoenix LLC and Shine Medical Technologies LLC, nuclear technology companies focused on near-term
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...